Tower Research Capital LLC (Trc) In8 Bio, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in In8 Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 18,575 shares of INAB stock, worth $5,015. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,575
Previous 13,189
40.84%
Holding current value
$5,015
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding INAB
# of Institutions
27Shares Held
30MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX8.6MShares$2.32 Million2.31% of portfolio
-
Aigh Capital Management LLC Baltimore, MD6.19MShares$1.67 Million0.68% of portfolio
-
Franklin Resources Inc San Mateo, CA5.7MShares$1.54 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL5.06MShares$1.37 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$384,4520.0% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $6.62M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...